TREATMENT AND DIAGNOSIS OF FUNCTIONAL DYSPEPSIA IN PEOPLE WITH DIABETES 2 TYPES
Keywords:
dyspepsia syndrome, type 2 diabetes mellitus, Helicobacter pylori.Abstract
Diabetes mellitus (DM) is a group of metabolic diseases characterized by high rates of morbidity [1, 2] and systemic complications involving various organs and systems, including the gastrointestinal tract [1-3]. Symptoms of dyspepsia are among the most common complaints related to digestive disorders and occur in 25% of the population [4, 5]. The concept of dyspepsia has been repeatedly revised and clarified. According to the Rome Criteria II (1999), dyspepsia is understood as a feeling of pain or discomfort, early satiety, overflow localized in the epigastric region, as well as bloating or nausea [6]. Based on the assessment of the leading clinical manifestation, dyskinetic and ulcer-like variants of dyspepsia syndrome are distinguished [6-8].
References
Dedov I., Shestakova M.V. Algorithms of specialized medical care for patients with diabetes mellitus. Diabetes mellitus Supplement to the journal 2011; 3: 1-72.
Dedov I.I., Melnichenko G.A. Endocrinology: A national guide. Moscow: GEOTAR-Media 2011; 120-151, 253-329.
Leites Yu.G., Galstyan G.R., Marchenko E.V. Gastroenterological complications of diabetes mellitus. Medical consultation Diligence: Gastroenterology 2007; 2: 25-32.
Harmon R.S., Peura D.A. Assessment and treatment of dyspepsia. Gastroenterol Publishing House, 2010; 3 (2): 87-98.
Tack J., Talley N.J., Camilleri M. et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130 (5): 1466-1479.
Talley, N.J., Stangellini, V., Heding, R. S., and others. Functional gastroduodenal disorders. Gut 1999; 45 (Supplement II): II37—II42.
Keohane J., Quigley E.M. Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis. The World of Gastroenterology, 2006; 12 (17): 2672-2676.
Talley N.J., Stangellini V., Heding R.S. and others. Constitutional officials. In: Drosman D.A. (ed.) Rome II. Functional Gastrointestinal Disorders, 2nd ed. Allen Press 2000: 299-350.
Abid S., Rizvi A., Jahan F. Poor glycemic control is the main factor associated with an increased incidence of gastrointestinal symptoms in patients with diabetes mellitus. Jay Park, Associate Professor of Medicine, 2007; 57 (7): 345-349.
Oh J.H., Choi M.J., Kang M.I. and others. Prevalence of gastrointestinal symptoms in patients with non-insulin-dependent diabetes mellitus. Korean International Medical Journal, 2009; 24 (4): 309-317.
Devrajani B.R., S. Shah Z., And Soomro A., Devrajani T. Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: a case-control clinical trial. International Diabetes Research, 2010; 30 (1): 22-26.
Gulchelik N. E., Kaya E., Demirbas B. et al. The prevalence of Helicobacter pylori in patients with diabetes mellitus and its association with dyspepsia and autonomic neuropathy. J Endocrinol Invest, 2005; 28 (3): 214-217.
Kuan S., Talley N.J., Jones M.P. and others. Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol, 2008; 20 (9): 888-897.
